Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print April 15, 2009, doi:10.1212/01.wnl.0000346516.49126.20)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Podcast
Right arrow All Versions of this Article:
01.wnl.0000346516.49126.20v1
72/24/2068    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Cloak, C. C.
Right arrow Articles by Chang, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cloak, C. C.
Right arrow Articles by Chang, L.
Related Collections
Right arrow DWI
Right arrow All Pediatric
Right arrow Other toxicology
Right arrowRelated Article
NEUROLOGY 2009;72:2068-2075
© 2009 American Academy of Neurology

Lower diffusion in white matter of children with prenatal methamphetamine exposure

C. C. Cloak, PhD, T. Ernst, PhD, L. Fujii, MD, B. Hedemark, BA and L. Chang, MD

From the Department of Medicine, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu.

Address correspondence and reprint requests to Dr. Christine Cloak, Department of Medicine, John A. Burns School of Medicine, Queen’s University Tower, 1356 Lusitana Street, Honolulu, HI 96813 cloak{at}hawaii.edu

Background: Methamphetamine use is a common problem among women of childbearing age, leading to an increasing number of children with prenatal methamphetamine exposure. Whether microstructural brain changes associated with prenatal methamphetamine exposure can be detected with diffusion tensor imaging (DTI) is unknown.

Method: Twelve-direction DTI was performed in 29 methamphetamine-exposed and 37 unexposed children ages 3–4 years on a 3-T MRI scanner. Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were determined in the corpus callosum (genu and splenium) and bilaterally in the frontal and parietal white matter (WM), basal ganglia (caudate, putamen, globus pallidus), and thalamus.

Results: Children with prenatal methamphetamine exposure had lower ADC in the frontal (right: –2.1%, p = 0.04; left: –2.0%, p = 0.09) and parietal WM (right: –3.9%, p = 0.002; left: –3.3%, p = 0.02) compared to unexposed children. The methamphetamine-exposed children also showed a trend for higher FA in the left frontal WM (+4.9%, p = 0.06) compared to the unexposed children.

Conclusion: Since less myelination and higher dendritic or spine density have been reported in animals exposed to methamphetamine, lower diffusion in our children may reflect more compact axons or greater dendritic or spine density associated with prenatal methamphetamine exposure. These findings suggest alterations in white matter maturation in these children exposed to methamphetamine in utero.

Abbreviations: ADC = apparent diffusion coefficient; ANOVA = analysis of variance; ASI = Addiction Severity Index; CES-D = Center for Epidemiologic Studies–Depression scale; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; DTI = diffusion tensor imaging; EPI = echoplanar imaging; FA = fractional anisotropy; ISP = Index of Social Position; NART-R = National Adult Reading Test; ROI = region of interest; SASSI = Substance Abuse Subtle Screening Inventory; TE = echo time; TI = inversion time; TR = repetition time; VIQ = verbal intelligence; WM = white matter.


Editorial, page 2062

e-Pub ahead of print on April 15, 2009, at www.neurology.org.

Supported by funds from the National Institute on Drug Abuse (R01-DA21016-LC, K24-DA16170-LC; K02-DA16991-TE; K01-DA021203-CC) and core resources from the National Center for Research Resources (G12 RR003061-21, 1P01 RR011091-11), the National Institute of Neurological Disorders and Stroke (U54 NS56883), and the Office of National Drug Control Policy.

Disclosure: The authors report no disclosures.

Medical Devices: Siemens Trio scanner (Siemens Medical Solutions, Erlangen, Germany).

Received July 8, 2008. Accepted in final form December 22, 2008.


Related Article

Still no time for complacency: Developmental effects of prenatal methamphetamine exposure
C. J. Malanga
Neurology 2009 72: 2062-2063. [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.